Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

Dean M. Wingerchuk

doi:10.1177/1352458519837924

Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

Dean M. Wingerchuk

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1220-1222
Number of pages	3
Journal	Multiple Sclerosis Journal
Volume	25
Issue number	9
DOIs	https://doi.org/10.1177/1352458519837924
State	Published - Aug 1 2019

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1177/1352458519837924

Cite this

@article{fd5893219f8146c0837714b3cfef5405,

title = "Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary",

author = "Wingerchuk, {Dean M.}",

year = "2019",

month = aug,

day = "1",

doi = "10.1177/1352458519837924",

language = "English (US)",

volume = "25",

pages = "1220--1222",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "9",

}

TY - JOUR

T1 - Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

AU - Wingerchuk, Dean M.

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85063334201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063334201&partnerID=8YFLogxK

U2 - 10.1177/1352458519837924

DO - 10.1177/1352458519837924

M3 - Comment/debate

C2 - 30900942

AN - SCOPUS:85063334201

SN - 1352-4585

VL - 25

SP - 1220

EP - 1222

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 9

ER -

Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this